Skip to main content

Labeled for this condition

Medicines for pulmonary arterial hypertension

11 medicines have an FDA label indicated for pulmonary arterial hypertension; 9 are listed from generic labelers and 0 have a presentation in shortage now (FDA files, October 8, 2026).

Which medicines are labeled for pulmonary arterial hypertension?

Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.

Recalls: FDA enforcement reports, 2012 on
MedicineBrand namesGeneric labelers (all forms)Pharmacy costBoxed warningShortageRecalls since 2012
TadalafilCialis, Tadliq, Adcirca49 labelers$0.167 per tablet 20 mg tabletNoNo current entry12
SildenafilViagra, Vybrique, Revatio60 labelers$0.132 per tablet 100 mg tabletNoNo current entry2
TreprostinilTyvaso, Orenitram, Remodulin4 labelersn/aNoNo current entry1
SelexipagUptravi2 labelersn/aNoNo current entry0
AmbrisentanLetairis12 labelers$8.02 per tablet 10 mg tabletYesNo current entry0
MacitentanOpsumit13 labelersn/aYesNo current entry0
BosentanTracleer5 labelersn/aYesNo current entry0
RiociguatAdempas1 labelern/aYesNo current entry0
EpoprostenolVeletri3 labelersn/aNoNo current entry3
Sotatercept-csrkWinrevairnone listedn/aNoNo current entry0
Macitentan and tadalafilOpsynvinone listedn/aYesNo current entry0

Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)

What do pharmacies pay?

Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.

Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price

What next?